CBLAX
Price
$52.53
Change
-$0.49 (-0.92%)
Updated
Jun 13 closing price
Net Assets
9.61B
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

CBLAX vs RLBCX

Header iconCBLAX vs RLBCX Comparison
Open Charts CBLAX vs RLBCXBanner chart's image
Columbia Balanced A
Price$52.53
Change-$0.49 (-0.92%)
VolumeN/A
Net Assets9.61B
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
CBLAX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBLAX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLAX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. CBLAX (9.61B). CBLAX pays higher dividends than RLBCX: CBLAX (1.77) vs RLBCX (1.63). CBLAX was incepted earlier than RLBCX: CBLAX (23 years) vs RLBCX (23 years). CBLAX (0.93) and RLBCX (0.89) have similar cost to investors . CBLAX is a more actively managed with annual turnover of: 200.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than CBLAX: RLBCX (250) vs CBLAX (2000). RLBCX annual gain was more profitable for investors over the last year : 4.94 vs. CBLAX (1.39). RLBCX return over 5 years is better than : 36.51 vs. CBLAX (28.73).
CBLAXRLBCXCBLAX / RLBCX
Total Expense Ratio0.930.89104%
Annual Report Gross Expense Ratio0.930.89104%
Fund Existence23 years23 years-
Gain YTD2.6384.29461%
Front Load6%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets9.61B244B4%
Annual Yield % from dividends1.771.63108%
Returns for 1 year1.394.9428%
Returns for 3 years30.4831.5497%
Returns for 5 years28.7336.5179%
Returns for 10 years53.7554.9998%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd